Literature DB >> 15611389

Drug therapy in the heart transplant recipient: part II: immunosuppressive drugs.

JoAnn Lindenfeld1, Geraldine G Miller, Simon F Shakar, Ronald Zolty, Brian D Lowes, Eugene E Wolfel, Luisa Mestroni, Robert L Page, Jon Kobashigawa.   

Abstract

Mesh：

Substances：

Year:  2004        PMID： 15611389     DOI： 10.1161/01.CIR.0000150332.42276.69

Source DB:  PubMed          Journal:  Circulation        ISSN： 0009-7322            Impact factor:   29.690


× No keyword cloud information.
  43 in total

1.  FK506 binding protein 12 deficiency in endothelial and hematopoietic cells decreases regulatory T cells and causes hypertension.

Authors:  Valorie L Chiasson; Deepa Talreja; Kristina J Young; Piyali Chatterjee; Amy K Banes-Berceli; Brett M Mitchell
Journal:  Hypertension       Date:  2011-04-25       Impact factor: 10.190

2.  Pin1 deficiency causes endothelial dysfunction and hypertension.

Authors:  Valorie L Chiasson; Nidhi Munshi; Piyali Chatterjee; Kristina J Young; Brett M Mitchell
Journal:  Hypertension       Date:  2011-08-01       Impact factor: 10.190

Review 3.  Surgical biology for the clinician: vascular effects of immunosuppression.

Authors:  Elissa Tepperman; Danny Ramzy; Jessica Prodger; Rohit Sheshgiri; Mitesh Badiwala; Heather Ross; Vivek Raoa
Journal:  Can J Surg       Date:  2010-02       Impact factor: 2.089

4.  Rapamycin impairs trabecular bone acquisition from high-dose but not low-dose intermittent parathyroid hormone treatment.

Authors:  P J Niziolek; S Murthy; S N Ellis; K B Sukhija; T A Hornberger; C H Turner; A G Robling
Journal:  J Cell Physiol       Date:  2009-12       Impact factor: 6.384

Review 5.  Complications of Cardiac Transplantation.

Authors:  Luciano Potena; Andreas Zuckermann; Francesco Barberini; Arezu Aliabadi-Zuckermann
Journal:  Curr Cardiol Rep       Date:  2018-07-10       Impact factor: 2.931

6.  Deficiency of cardiac Acyl-CoA synthetase-1 induces diastolic dysfunction, but pathologic hypertrophy is reversed by rapamycin.

Authors:  David S Paul; Trisha J Grevengoed; Florencia Pascual; Jessica M Ellis; Monte S Willis; Rosalind A Coleman
Journal:  Biochim Biophys Acta       Date:  2014-03-12

7.  Myeloid-Derived Suppressor Cells Ameliorate Cyclosporine A-Induced Hypertension in Mice.

Authors:  Valorie L Chiasson; Kelsey R Bounds; Piyali Chatterjee; Lochana Manandhar; Abhinandan R Pakanati; Marcos Hernandez; Bilal Aziz; Brett M Mitchell
Journal:  Hypertension       Date:  2017-11-13       Impact factor: 10.190

8.  How to demonstrate the reversibility of end-organ function before implantation of left ventricular assist device in INTERMACS profile 2 patients?

Authors:  Teruhiko Imamura; Koichiro Kinugawa; Taro Shiga; Naoko Kato; Miyoko Endo; Toshiro Inaba; Hisataka Maki; Masaru Hatano; Atsushi Yao; Yasunobu Hirata; Masaaki Akahane; Takashi Nishimura; Shunei Kyo; Minoru Ono; Ryozo Nagai
Journal:  J Artif Organs       Date:  2012-07-17       Impact factor: 1.731

Review 9.  Cardiac allograft vasculopathy and insulin resistance--hope for new therapeutic targets.

Authors:  Luciano Potena; Hannah A Valantine
Journal:  Endocrinol Metab Clin North Am       Date:  2007-12       Impact factor: 4.741

10.  Cyclosporine up-regulates Krüppel-like factor-4 (KLF4) in vascular smooth muscle cells and drives phenotypic modulation in vivo.

Authors:  Sean M Garvey; Daniel S Sinden; Pamela D Schoppee Bortz; Brian R Wamhoff
Journal:  J Pharmacol Exp Ther       Date:  2010-01-20       Impact factor: 4.030
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.